- Home
- FLEX vs NBIX Comparison
FLEX vs NBIX Comparison
Compare FLEX & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLEX
- NBIX
- Stock Information
- Founded
- FLEX 1990
- NBIX 1992
- Country
- FLEX United States
- NBIX United States
- Employees
- FLEX N/A
- NBIX N/A
- Industry
- FLEX Electrical Products
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLEX Technology
- NBIX Health Care
- Exchange
- FLEX Nasdaq
- NBIX Nasdaq
- Market Cap
- FLEX 13.7B
- NBIX 11.8B
- IPO Year
- FLEX 1994
- NBIX 1996
- Fundamental
- Price
- FLEX $41.25
- NBIX $124.90
- Analyst Decision
- FLEX Strong Buy
- NBIX Buy
- Analyst Count
- FLEX 6
- NBIX 24
- Target Price
- FLEX $40.83
- NBIX $163.91
- AVG Volume (30 Days)
- FLEX 3.2M
- NBIX 1.1M
- Earning Date
- FLEX 10-30-2024
- NBIX 10-30-2024
- Dividend Yield
- FLEX N/A
- NBIX N/A
- EPS Growth
- FLEX 30.53
- NBIX 97.40
- EPS
- FLEX 2.26
- NBIX 3.73
- Revenue
- FLEX $25,449,000,000.00
- NBIX $2,242,800,000.00
- Revenue This Year
- FLEX N/A
- NBIX $26.97
- Revenue Next Year
- FLEX $5.26
- NBIX $16.69
- P/E Ratio
- FLEX $17.64
- NBIX $33.06
- Revenue Growth
- FLEX N/A
- NBIX 25.72
- 52 Week Low
- FLEX $18.80
- NBIX $109.77
- 52 Week High
- FLEX $40.48
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- FLEX 69.09
- NBIX 54.00
- Support Level
- FLEX $36.56
- NBIX $115.27
- Resistance Level
- FLEX $40.30
- NBIX $124.01
- Average True Range (ATR)
- FLEX 1.08
- NBIX 3.19
- MACD
- FLEX 0.08
- NBIX -0.22
- Stochastic Oscillator
- FLEX 93.46
- NBIX 53.89
About FLEX Flex Ltd.
Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.